Literature DB >> 32691361

Genome Sequencing of Leishmania infantum Causing Cutaneous Leishmaniosis from a Turkish Isolate with Next-Generation Sequencing Technology.

Dilek Guldemir1,2, Selma Usluca3, Ayse Serpil Nalbantoglu4.   

Abstract

PURPOSE: Leishmania subgenus Leishmania causes leishmaniosis, which is a chronic systemic disease in humans and animals, in which the skin and visceral organs can be affected. The disease generally consists of three different clinical types in humans: visceral (kala-azar, VL), cutaneous (CL) and mucocutaneous leishmaniosis (MCL). According to the World Health Organization (WHO), leishmaniosis is still one of the world's most neglected diseases. It has been nearly 13-14 years since the completion of the first complete genome sequence of a Leishmania parasite. However, much information about these parasites remains to be elucidated, such as the causes of differences in tissue tropism. The aim of this study is to perform the whole-genome sequencing of Leishmania infantum causing cutaneous leishmaniosis from a Turkish isolate with next-generation sequencing technology.
METHODS: Genomic sequencing was performed on the Illumina HiSeq 2500 platform. The TruSeq Nano DNA Low Throughput Library Prep Kit, compatible with the Illumina HiSeq 2500 platform, was used to generate the library. Synthesis sequencing (SBS) was performed with a HiSeq Rapid SBS Kit v2 to generate single-fragment reads (2 × 150 bp; PE) with two fragment end-to-end assemblies. Bioinformatics analyses were performed on the Geneious 11.0.5. ( www.genius.com ) platform.
RESULTS: In our study, a high-quality whole-genome sequence (WGS) of L. infantum was successfully generated, and a total of 32,009,137 base pairs of genomic DNA from 36 chromosomes were obtained. The resulting genomic DNA sequence was submitted to the US National Center for Biotechnology Information (NCBI) GenBank ( www.ncbi.nlm.nih.gov ) database and registered under the name Leishmania infantum_TR01 (Lin_TR01). The following accession numbers were assigned by NCBI to the 36 chromosomes of the Lin_TR01 genome: CP027807, CP027810, CP027808, CP027811, CP027809, CP027812, CP027813, CP027814, CP027817, CP027818, CP027819, CP027815, CP027821, CP027816, CP027823, CP027820, CP027822, CP027824, CP027825, CP027826, CP027827, CP027828, CP027829, CP027830, CP027831, CP027832, CP027833, CP027834, CP027835, CP027836, CP027837, CP027838, CP027839, CP027840, CP027841, CP027842. As a result of the annotation of the Lin_TR01 genome, 3153 polymorphisms, 8324 genes, 8199 CDSs, 8109 mRNAs, 67 tRNAs, 11 rRNAs and 58 ncRNA were identified. Among the 8199 CDS obtained, 5278 encode hypothetical proteins.
CONCLUSION: In this study, a high-quality WGS of Leishmania infantum was successfully obtained for the first time in Turkey. According to a review of WGS studies on this subject, the Lin_TR01 strain is the first strain to be isolated from cutaneous leishmaniosis. The reference genome of L. infantum JPCM5 (Peacock et al., 2007) was obtained from a visceral leishmaniosis case, in accordance with the classical tissue and organ tropism of the species. Lin_TR01 is the second whole-genome-sequenced strain in the world after the JPCM5 strain. The Lin_TR01 genome is the only L. infantum whole-genome sequence that is completed assembly level from 36 chromosomes among the genomes obtained thus far ( https://www.ncbi.nlm.nih.gov/genome/genomes/249 ).

Entities:  

Keywords:  Cutaneous leishmaniosis; Leishmania infantum; Next-generation sequencing technology; Whole-genome sequencing

Year:  2020        PMID: 32691361     DOI: 10.1007/s11686-020-00252-9

Source DB:  PubMed          Journal:  Acta Parasitol        ISSN: 1230-2821            Impact factor:   1.440


  11 in total

1.  Chromosome and gene copy number variation allow major structural change between species and strains of Leishmania.

Authors:  Matthew B Rogers; James D Hilley; Nicholas J Dickens; Jon Wilkes; Paul A Bates; Daniel P Depledge; David Harris; Yerim Her; Pawel Herzyk; Hideo Imamura; Thomas D Otto; Mandy Sanders; Kathy Seeger; Jean-Claude Dujardin; Matthew Berriman; Deborah F Smith; Christiane Hertz-Fowler; Jeremy C Mottram
Journal:  Genome Res       Date:  2011-10-28       Impact factor: 9.043

2.  Whole genome sequencing of multiple Leishmania donovani clinical isolates provides insights into population structure and mechanisms of drug resistance.

Authors:  Tim Downing; Hideo Imamura; Saskia Decuypere; Taane G Clark; Graham H Coombs; James A Cotton; James D Hilley; Simonne de Doncker; Ilse Maes; Jeremy C Mottram; Mike A Quail; Suman Rijal; Mandy Sanders; Gabriele Schönian; Olivia Stark; Shyam Sundar; Manu Vanaerschot; Christiane Hertz-Fowler; Jean-Claude Dujardin; Matthew Berriman
Journal:  Genome Res       Date:  2011-10-28       Impact factor: 9.043

3.  The genome of the kinetoplastid parasite, Leishmania major.

Authors:  Alasdair C Ivens; Christopher S Peacock; Elizabeth A Worthey; Lee Murphy; Gautam Aggarwal; Matthew Berriman; Ellen Sisk; Marie-Adele Rajandream; Ellen Adlem; Rita Aert; Atashi Anupama; Zina Apostolou; Philip Attipoe; Nathalie Bason; Christopher Bauser; Alfred Beck; Stephen M Beverley; Gabriella Bianchettin; Katja Borzym; Gordana Bothe; Carlo V Bruschi; Matt Collins; Eithon Cadag; Laura Ciarloni; Christine Clayton; Richard M R Coulson; Ann Cronin; Angela K Cruz; Robert M Davies; Javier De Gaudenzi; Deborah E Dobson; Andreas Duesterhoeft; Gholam Fazelina; Nigel Fosker; Alberto Carlos Frasch; Audrey Fraser; Monika Fuchs; Claudia Gabel; Arlette Goble; André Goffeau; David Harris; Christiane Hertz-Fowler; Helmut Hilbert; David Horn; Yiting Huang; Sven Klages; Andrew Knights; Michael Kube; Natasha Larke; Lyudmila Litvin; Angela Lord; Tin Louie; Marco Marra; David Masuy; Keith Matthews; Shulamit Michaeli; Jeremy C Mottram; Silke Müller-Auer; Heather Munden; Siri Nelson; Halina Norbertczak; Karen Oliver; Susan O'neil; Martin Pentony; Thomas M Pohl; Claire Price; Bénédicte Purnelle; Michael A Quail; Ester Rabbinowitsch; Richard Reinhardt; Michael Rieger; Joel Rinta; Johan Robben; Laura Robertson; Jeronimo C Ruiz; Simon Rutter; David Saunders; Melanie Schäfer; Jacquie Schein; David C Schwartz; Kathy Seeger; Amber Seyler; Sarah Sharp; Heesun Shin; Dhileep Sivam; Rob Squares; Steve Squares; Valentina Tosato; Christy Vogt; Guido Volckaert; Rolf Wambutt; Tim Warren; Holger Wedler; John Woodward; Shiguo Zhou; Wolfgang Zimmermann; Deborah F Smith; Jenefer M Blackwell; Kenneth D Stuart; Bart Barrell; Peter J Myler
Journal:  Science       Date:  2005-07-15       Impact factor: 47.728

4.  Low plasma membrane expression of the miltefosine transport complex renders Leishmania braziliensis refractory to the drug.

Authors:  María P Sánchez-Cañete; Luís Carvalho; F Javier Pérez-Victoria; Francisco Gamarro; Santiago Castanys
Journal:  Antimicrob Agents Chemother       Date:  2009-02-02       Impact factor: 5.191

5.  Retention and loss of RNA interference pathways in trypanosomatid protozoans.

Authors:  Lon-Fye Lye; Katherine Owens; Huafang Shi; Silvane M F Murta; Ana Carolina Vieira; Salvatore J Turco; Christian Tschudi; Elisabetta Ullu; Stephen M Beverley
Journal:  PLoS Pathog       Date:  2010-10-28       Impact factor: 6.823

6.  Conserved linkage groups associated with large-scale chromosomal rearrangements between Old World and New World Leishmania genomes.

Authors:  C Britto; C Ravel; P Bastien; C Blaineau; M Pagès; J P Dedet; P Wincker
Journal:  Gene       Date:  1998-11-05       Impact factor: 3.688

7.  Genome sequencing of the lizard parasite Leishmania tarentolae reveals loss of genes associated to the intracellular stage of human pathogenic species.

Authors:  Frédéric Raymond; Sébastien Boisvert; Gaétan Roy; Jean-François Ritt; Danielle Légaré; Amandine Isnard; Mario Stanke; Martin Olivier; Michel J Tremblay; Barbara Papadopoulou; Marc Ouellette; Jacques Corbeil
Journal:  Nucleic Acids Res       Date:  2011-10-13       Impact factor: 16.971

Review 8.  The past, present, and future of Leishmania genomics and transcriptomics.

Authors:  Cinzia Cantacessi; Filipe Dantas-Torres; Matthew J Nolan; Domenico Otranto
Journal:  Trends Parasitol       Date:  2015-01-28

9.  The genome sequence of Leishmania (Leishmania) amazonensis: functional annotation and extended analysis of gene models.

Authors:  Fernando Real; Ramon Oliveira Vidal; Marcelo Falsarella Carazzolle; Jorge Maurício Costa Mondego; Gustavo Gilson Lacerda Costa; Roberto Hirochi Herai; Martin Würtele; Lucas Miguel de Carvalho; Renata Carmona e Ferreira; Renato Arruda Mortara; Clara Lucia Barbiéri; Piotr Mieczkowski; José Franco da Silveira; Marcelo Ribeiro da Silva Briones; Gonçalo Amarante Guimarães Pereira; Diana Bahia
Journal:  DNA Res       Date:  2013-07-15       Impact factor: 4.458

10.  Comparative genomic analysis of three Leishmania species that cause diverse human disease.

Authors:  Christopher S Peacock; Kathy Seeger; David Harris; Lee Murphy; Jeronimo C Ruiz; Michael A Quail; Nick Peters; Ellen Adlem; Adrian Tivey; Martin Aslett; Arnaud Kerhornou; Alasdair Ivens; Audrey Fraser; Marie-Adele Rajandream; Tim Carver; Halina Norbertczak; Tracey Chillingworth; Zahra Hance; Kay Jagels; Sharon Moule; Doug Ormond; Simon Rutter; Rob Squares; Sally Whitehead; Ester Rabbinowitsch; Claire Arrowsmith; Brian White; Scott Thurston; Frédéric Bringaud; Sandra L Baldauf; Adam Faulconbridge; Daniel Jeffares; Daniel P Depledge; Samuel O Oyola; James D Hilley; Loislene O Brito; Luiz R O Tosi; Barclay Barrell; Angela K Cruz; Jeremy C Mottram; Deborah F Smith; Matthew Berriman
Journal:  Nat Genet       Date:  2007-06-17       Impact factor: 38.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.